埃弗B4-埃弗林-B2是割抵抗性前列腺癌的点
Grace Xiuqing Li1, Binyun Ma1, Shaobing Zhang1
1Department of Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
研究PI3K通路在前列腺癌发病和进展中的作用. 向EphB4 (素生成性肝细胞癌B4) 显示出治疗早期和割抵抗性前列腺癌的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 酸3-酶 (PI3K) 路径激活是前列腺癌的早期事件,通常是由于PTEN损失或PIK3CA/AKT突变.
- 这种激活可以导致诱导EphB4 (产生的 erythropoietin 肝细胞癌 B4) 和其连接物以林-B2.
- 我们假设EphB4对于瘤发作和前列腺癌的进展至关重要.
研究的目的:
- 调查EphB4在前列腺癌发病中的作用.
- 为了确定EphB4信号是否与雄激素独立前列腺癌相关.
- 评估针对EphB4通路的治疗潜力.
主要方法:
- 使用了一种基因小鼠模型,在前列腺上皮上有条件的PTEN删除.
- 通过比较野生类型和删除的EPHB4模型来测试EphB4的作用.
- 使用一种诱溶性EphB4 (sEphB4-alb) 融合蛋白来阻止EphB4-ephrin-B2信号传递.
- 在缺乏雄激素的小鼠中评估了EphB4-ephrin-B2通路活性,以模拟耐火性癌症.
主要成果:
- 在前列腺瘤中,PTEN删除诱导了EphB4和ephrin-B2;EPHB4删除显著降低了这种诱导.
- sEphB4-alb融合蛋白抑制了瘤形成,证实了EphB4在启动中的作用.
- 抑制EphB4在抵抗割的前列腺癌模型中仍然有效,不依赖于雄激素.
- 对EphB4通路的药理抑制证实了这些发现.
结论:
- 埃弗B4-埃弗林-B2对在PTEN-null前列腺癌中被诱导,并对瘤启动有显著的贡献.
- 这一途径促进瘤的进展,即使在缺少雄激素的,耐激素的前列腺癌中也是如此.
- 在前列腺癌中,ephB4和ephrin-B2可以作为精密医学的治疗标,以生物标志物为基础的患者选择.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
